References
- 1. Choosing Wisely/Good Stewardship – National Physicians Alliance, Available at: http://npalliance.org/promoting-goodstewardship-in-medicine-project/ [accessed. 2018-10-07].
- 2. GOOD STEWARDSHIP WORKING GROUP. The “top 5” lists in primary care: meeting the responsibility of professionalism. Arch. Intern. Med. 2011;171(15):1385–90.
- 3. Choosing Wisely, Available at: http://www.choosingwisely.org/ [accessed. 2018-05-20].
- 4. Choosing Wisely Canada, Available at: https://choosingwiselycanada.org/ [accessed. 2018-05-20].
- 5. Choosing Wisely Australia, Available at: http://www.choosingwisely.org.au/home [accessed. 2018-05-20].
- 6. Choosing Wisely UK, Available at: http://www.choosingwisely.co.uk/ [accessed. 2018-05-20].
- 7. MONTANO, N., COSTANTINO, G., CASAZZA, G., SBROJAVACCA, R., LENTI, M.V., FALSETTI, L., et al. The Italian Society of Internal Medicine choosing wisely campaign. Intern. Emerg. Med. 2016;11(8):1125–1130.
- 8. LUSIANI, L., FREDIANI, R., NARDI, R., FONTANELLA, A., CAMPANINI, M. Doing more does not mean doing better: The FADOI contribution to the Slow Medicine program for a sustainable and wise healthcare system. Ital. J. Med. 2015;9(3):281–286.
- 9. SELBY, K., GASPOZ, J.-M., RODONDI, N., NEUNER-JEHLE, S., PERRIER, A., ZELLER, A., et al. Creating a list of low-value health care activities in Swiss primary care. JAMA Intern. Med. 2015;175(4):640.
- 10. CHAN, W.S., LEUNG, A.Y. Use of Social Network sites for communication among health professionals: systematic review. J. Med. Internet Res. 2018;20(3):e117.
- 11. THILLAINADESAN, J., GNJIDIC, D., GREEN, S., HILMER, S.N. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging 2018;35(4):303–319.
- 12. SCOTT, I.A., ANDERSON, K., FREEMAN, C.R., STOWASSER, D.A. First do no harm: a real need to deprescribe in older patients. Med. J. Aust. 2014;201(7):390–2.
- 13. REEVE, E., GNJIDIC, D., LONG, J., HILMER, S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br. J. Clin. Pharmacol. 2015;80(6):1254–68.
- 14. PAGE, A.T., CLIFFORD, R.M., POTTER, K., SCHWARTZ, D., ETHERTON-BEER, C.D. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br. J. Clin. Pharmacol. 2016;82(3):583–623.
- 15. THIO, S.L., NAM, J., VAN DRIEL, M.L., DIRVEN, T., BLOM, J.W. Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials. Br. J. Gen. Pract. 2018;68(675):e663–e672.
- 16. O’MAHONY, D., O’SULLIVAN, D., BYRNE, S., O’CONNOR, M.N., RYAN, C., GALLAGHER, P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2014;44(2):213–218.
- 17. HILL-TAYLOR, B., WALSH, K.A., STEWART, S., HAYDEN, J., BYRNE, S., SKETRIS, I.S. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J. Clin. Pharm. Ther. 2016;41(2):158–169.
- 18. BY THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA UPDATE EXPERT PANEL. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 2015;63(11):2227–2246.
- 19. LEVY, H.B. Polypharmacy reduction strategies. Clin. Geriatr. Med. 2017;33(2):177–187.
- 20. POPESCU, G.A., SERBAN, R., PISTOL, A., NICULCEA, A., PREDA, A., LEMENI, D., et al. The recent emergence of Clostridium difficile infection in Romanian hospitals is associated with a high prevalence of polymerase chain reaction ribotype 027. Balkan Med. J. 2018;35(2):191–195.
- 21. DREKONJA, D.M., AMUNDSON, W.H., DECAROLIS, D.D., KUSKOWSKI, M.A., LEDERLE, F.A., JOHNSON, J.R. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am. J. Med. 2011;124(11):1081.e1-1081.e7.
- 22. SMITS, W.K., LYRAS, D., LACY, D.B., WILCOX, M.H., KUIJPER, E.J. Clostridium difficile infection. Nat. Rev. Dis. Prim. 2016;2:16020.
- 23. SHAUGHNESSY, M.K., AMUNDSON, W.H., KUSKOWSKI, M.A., DECAROLIS, D.D., JOHNSON, J.R., DREKONJA, D.M. Unnecessary Antimicrobial use in patients with current or recent Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 2013;34(02):109–116
- 24. POPESCU, G.-A., CODIŢĂ, I., TĂLĂPAN, D., ŞERBAN, R., RUJA, G. Ghid de diagnostic, tratament şi prevenire a infecţiilor determinate de Clostridium difficile (Ediţia a 2-a). b.n. Available at: http://mainicurateinspitale.ro/wpcontent/uploads/2016/08/Ghid-diagnostic-tratament-si-prevenire-Clostridium-difficile.pdf.
- 25. ALLEN, C., GLASZIOU, P., DEL MAR, C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet (London, England) 1999;354(9186):1229–33.
- 26. LIPSHUTZ, A.K.M., GROPPER, M.A. Acquired neuromuscular weakness and early mobilization in the intensive care unit. Anesthesiology 2013;118(1):202–215.
- 27. HASHEM, M.D., PARKER, A.M., NEEDHAM, D.M. Early mobilization and rehabilitation of patients who are critically ill. Chest 2016;150(3):722–31.
- 28. APPLETON, R.T., KINSELLA, J., QUASIM, T. The incidence of intensive care unit-acquired weakness syndromes: A systematic review. J. Intensive Care Soc. 2015;16(2):126–136.
- 29. SURKAN, M.J., GIBSON, W. Interventions to Mobilize elderly patients and reduce length of hospital stay. Can. J. Cardiol. 2018;34(7):881–888.
- 30. KALISCH, B.J., LEE, S., DABNEY, B.W. Outcomes of inpatient mobilization: a literature review. J. Clin. Nurs. 2014;23(11–12):1486–1501.
- 31. CENTERS FOR DISEASE CONTROL AND PREVENTION. Antibiotic resistance threats in the United States. b.n.Available at: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
- 32. ASLAM, B., WANG, W., ARSHAD, M., KHURSHID, M., MUZAMMIL, S., RASOOL, M., et al. Antibiotic resistance: a rundown of a global crisis. Infect. Drug Resist. 2018;11:1645–1658.
- 33. EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL. ECDC: SURVEILLANCE REPORT. Surveillance of antimicrobial resistance in Europe 2016, b.n., B.m., 2016.
- 34. LIXANDRU, B., COTAR, A., STRAUT, M., USEIN, C., CRISTEA, D., CIONTEA, S., et al. Carbapenemase-producing Klebsiella pneumoniae in Romania: A six-month survey. PLoS One 2015;10(11):e0143214.
- 35. GAVRILIU, L., POPESCU, G., POPESCU, C. Antimicrobial resistance of Pseudomonas aeruginosa in a Romanian hospital at the dawn of multidrug resistance. Brazilian J. Infect. Dis. 2016;20(5):509–510.
- 36. CUNHA, C. Antimicrobial stewardship programs: principles and practice. Med. Clin. North Am. 2018;102(5):797–803.
- 37. MANCHIKANTI, L., KAYE, A., KNEZEVIC, N., MCANALLY, H., SLAVIN, K., TRESCOT, A., et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician 2017;20(2S):S3–S92.
- 38. ELS, C., JACKSON, T., KUNYK, D., LAPPI, V., SONNENBERG, B., HAGTVEDT, R., et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst. Rev. 2017;10:CD012509.
- 39. FULTON-KEHOE, D., GARG, R., TURNER, J., BAUER, A., SULLIVAN, M., WICKIZER, T., et al. Opioid poisonings and opioid adverse effects in workers in Washington State. Am. J. Ind. Med. 2013;56(12):1452–1462.
- 40. LEE, S., CHOI, Y., PRANSKY, G. Extent and impact of opioid prescribing for acute occupational low back pain in the emergency department. J. Emerg. Med. 2016;50(3):376–384.e2.
- 41. HEGMANN, K., WEISS, M., BOWDEN, K., BRANCO, F., DUBRUELER, K., ELS, C., et al. ACOEM GUIDELINES ACOEM Practice guidelines: opioids and safety-sensitive work. JOEM 2014;56(7):e46-53.
- 42. DOCHERTY, A., TURGEON, A., WALSH, T. Best practice in critical care: anaemia in acute and critical illness. Transfus. Med. 2018;28(2):181–189.
- 43. DELANEY, M., WENDEL, S., BERCOVITZ, R., CID, J., COHN, C., DUNBAR, N., et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016;388(10061):2825–2836.
- 44. CARSON, J., TRIULZI, D., NESS, P. Indications for and adverse effects of red-cell transfusion. N. Engl. J. Med. 2017;377(13):1261–1272.
- 45. CARSON, J., STANWORTH, S., ROUBINIAN, N., FERGUSSON, D., TRIULZI, D., DOREE, C., et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst. Rev. 2016;10:CD002042.
- 46. CARSON, J., GUYATT, G., HEDDLE, N., GROSSMAN, B., COHN, C., FUNG, M., et al. Clinical practice guidelines from the AABB. JAMA 2016;316(19):2025.
- 47. HOVAGUIMIAN, F., MYLES, P. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2016;125(1):46–61.
- 48. GU, W.-J., GU, X.-P., WU, X.-D., CHEN, H., KWONG, J.S.W., ZHOU, L.-Y., et al. Restrictive versus liberal strategy for red blood-cell transfusion: a systematic review and meta-analysis in orthopaedic patients. J. Bone Joint Surg. Am. 2018; 100(8):686–695.